Our story
Cancer cell metastasis is the leading cause of cancer patient death. Approximately 90% of cancer patient deaths are caused by cancer cell metastasis. However, most clinical anti-cancer drugs are currently designed to inhibit the proliferationof cancer cells. There is a lack of drugs specifically designed to block cancercell metastasis, and there is no commercial high-throughput screening platform for efficiently identifying novel anti-metastatic drugs either. Future anti-tumor therapeutic strategies must adopt growth inhibitors, in combination with anti-metastasis drugs to treat advanced cancer patients, which will greatly improve the curative rate of cancer and significantly prolong patients' survival time. At Exploring Health LLC, we have successfully developed a high-throughput screening platform that can rapidly and efficiently identify anti-metastatic leading compounds. With our innovative high-throughput technology platform for screening anti-metastatic drugs, we are fully committed to developing anti-metastatic drugs to provide the medical industry with novelanti-cancer therapeutic strategies, which will revolutionize cancer therapeutics and significantly prolong patients' survival time.
Our mission
Enriching life by overcoming diseases.
Our vision
Developing drugs from multiple angles and safeguarding lives from different dimensions.
Our values
Accountability, Boldness, Cooperation, and Diversity.
Founder, CEO
Chief Technology Officer
Technical Consultant
Deputy General Manager